Richard Fatica

Dr. Richard Fatica

Transplant Surgery
26900 Cedar Road, 
Beachwood, OH 
On Staff At
Offers Telehealth
37 Years of Experience
26900 Cedar Road, 
Beachwood, OH 
OverviewInsuranceLocationsClinical Research

Overview

Richard Fatica is a Transplant Surgeon in Beachwood, Ohio. Dr. Fatica has been practicing medicine for over 37 years and is rated as an Experienced provider by MediFind in the treatment of Hyperaldosteronism. His top areas of expertise are Chronic Antibody-Mediated Rejection, Polycystic Kidney Disease, End-Stage Renal Disease (ESRD), Kidney Transplant, and Nephrectomy.

His clinical research consists of co-authoring 30 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution
Allegheny College, 1989.0
Residency
University of Pittsburgh Medical Center & Children's Hospital of Pittsburgh
Specialties
Transplant Surgery
Licenses
Internal Medicine in OH
Board Certifications
American Board Of Internal Medicine, 1999
Fellowships
University of Michigan Health System
Hospital Affiliations
Hillcrest Hospital
Cleveland Clinic
Akron General Medical Center
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

Beachwood Family Health and Surgery Center
26900 Cedar Road, Beachwood, OH 44122
Other Locations
Cleveland Clinic Main Campus
2050 East 96th Street, Cleveland, OH 44106

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Autosomal Dominant Polycystic Kidney Disease
A Phase 3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Autosomal Dominant Polycystic Kidney Disease
Enrollment Status: Terminated
Publish Date: June 03, 2025
Intervention Type: Drug
Study Drug: Bardoxolone
Study Phase: Phase 3
A Randomized Double-blind Placebo-controlled Study to Evaluate the Efficacy and Safety of Cinryze® (C1 Esterase Inhibitor [Human]) for the Treatment of Acute Antibody-mediated Rejection in Kidney Transplant Patients
A Randomized Double-blind Placebo-controlled Study to Evaluate the Efficacy and Safety of Cinryze® (C1 Esterase Inhibitor [Human]) for the Treatment of Acute Antibody-mediated Rejection in Kidney Transplant Patients
Enrollment Status: Terminated
Publish Date: July 13, 2020
Intervention Type: Drug, Biological
Study Phase: Phase 3
View 1 Less Clinical Trial

30 Total Publications

Improving the histologic detection of DSA-negative antibody-mediated rejection in kidney transplants.
Improving the histologic detection of DSA-negative antibody-mediated rejection in kidney transplants.
Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
Published: June 02, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Fatica's expertise for a condition
ConditionClose
    View All 19 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile